Samii A - Search Results

1

Head injury and risk of Parkinson disease: a systematic review and meta-analysis.

Jafari S, Etminan M, Aminzadeh F, Samii A. Jafari S, et al. Among authors: samii a. Mov Disord. 2013 Aug;28(9):1222-9. doi: 10.1002/mds.25458. Epub 2013 Apr 22. Mov Disord. 2013. PMID: 23609436 Review.

2

Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study.

Samii A, Turnbull IM, Kishore A, Schulzer M, Mak E, Yardley S, Calne DB. Samii A, et al. Brain. 1999 Mar;122 ( Pt 3):417-25. doi: 10.1093/brain/122.3.417. Brain. 1999. PMID: 10094251 Clinical Trial.

3

Manganese neurotoxicity: a review of clinical features, imaging and pathology.

Pal PK, Samii A, Calne DB. Pal PK, et al. Among authors: samii a. Neurotoxicology. 1999 Apr-Jun;20(2-3):227-38. Neurotoxicology. 1999. PMID: 10385886 Review.

4

Post-traumatic cervical dystonia: a distinct entity?

Samii A, Pal PK, Schulzer M, Mak E, Tsui JK. Samii A, et al. Can J Neurol Sci. 2000 Feb;27(1):55-9. doi: 10.1017/s0317167100051982. Can J Neurol Sci. 2000. PMID: 10676589

5

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.

Lee CS, Samii A, Sossi V, Ruth TJ, Schulzer M, Holden JE, Wudel J, Pal PK, de la Fuente-Fernandez R, Calne DB, Stoessl AJ. Lee CS, et al. Among authors: samii a. Ann Neurol. 2000 Apr;47(4):493-503. Ann Neurol. 2000. PMID: 10762161

6

Head tremor in cervical dystonia.

Pal PK, Samii A, Schulzer M, Mak E, Tsui JK. Pal PK, et al. Among authors: samii a. Can J Neurol Sci. 2000 May;27(2):137-42. Can J Neurol Sci. 2000. PMID: 10830347

7

Alternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson's disease and correlates with PET.

Pal PK, Lee CS, Samii A, Schulzer M, Stoessl AJ, Mak EK, Wudel J, Dobko T, Tsui JK. Pal PK, et al. Among authors: samii a. Parkinsonism Relat Disord. 2001 Oct;7(4):305-309. doi: 10.1016/s1353-8020(00)00048-1. Parkinsonism Relat Disord. 2001. PMID: 11344014

8

Transdermal dopaminergic D(2) receptor agonist therapy in Parkinson's disease with N-0923 TDS: a double-blind, placebo-controlled study.

Hutton JT, Metman LV, Chase TN, Juncos JL, Koller WC, Pahwa R, LeWitt PA, Samii A, Tsui JK, Calne DB, Waters CH, Calabrese VP, Bennett JP, Barrett R, Morris JL. Hutton JT, et al. Among authors: samii a. Mov Disord. 2001 May;16(3):459-63. doi: 10.1002/mds.1085. Mov Disord. 2001. PMID: 11391739 Clinical Trial.

9

Increased risk of somnolence with the new dopamine agonists in patients with Parkinson's disease: a meta-analysis of randomised controlled trials.

Etminan M, Samii A, Takkouche B, Rochon PA. Etminan M, et al. Among authors: samii a. Drug Saf. 2001;24(11):863-8. doi: 10.2165/00002018-200124110-00007. Drug Saf. 2001. PMID: 11665873

10

[18F]-Dopa positron emission tomography imaging in early-stage, non-parkin juvenile parkinsonism.

Pal PK, Leung J, Hedrich K, Samii A, Lieberman A, Nausieda PA, Calne DB, Breakefield XO, Klein C, Stoessl AJ. Pal PK, et al. Among authors: samii a. Mov Disord. 2002 Jul;17(4):789-94. doi: 10.1002/mds.10133. Mov Disord. 2002. PMID: 12210877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results